September
Accelerate Drug Discovery
with AI-driven Drug Design Virtual Boardroom
Online Agenda
Why you should attend
We invite you to contribute your expertise to an exclusive boardroom discussion about AI-driven Drug Discovery. Join us to discuss how science and technology can advance discovery by using the virtual twin to accelerate drug design.
Meet the Facilitator
The virtual boardroom will be lead by our expert facilitator
Jason Benedict
BIOVIA CEO & Vice President R&D Dassault Systèmes
More about BIOVIA, Dassault Systèmes
BIOVIA, a brand of Dassault Systèmes, provides a scientific collaborative environment for advanced biological, chemical and materials experiences that allows science-driven companies access, organize, analyze and share data in unprecedented ways throughout the product lifecycle in regulated and non-regulated environments. BIOVIA’s sophisticated enterprise portfolio of Scientific Informatics, Molecular Modeling & Simulation, Data Science, Laboratory Informatics, Formulation Design, Life Sciences Quality & Compliance and Manufacturing Analytics helps drive innovation, increase productivity, improve quality and compliance, reduce costs and accelerate time to market. BIOVIA is committed to enhancing and speeding innovation, increasing productivity, improving quality and compliance, reducing costs and accelerating product development for pharma and biotech companies around the world.”
Further Information
Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch.
Payment Securely powered by stripe
